Search

everythinglearnresearchcommunity

for

Search:↓

A reliable method was developed to measure Finasteride and Tadalafil together, showing they degrade under certain conditions.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Trichoscopy is crucial for accurately diagnosing fibrosing alopecia in pattern distribution.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

FFA's causes may include environmental triggers and genetic factors.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

More research needed to confirm finasteride as standard treatment for FFA.

The Cross-section Trichometer is a promising tool for measuring hair characteristics without cutting the hair and may have various clinical uses.

The drug was successfully released into hair follicles using nanocarriers.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Fipronil spray effectively treats ear mites in Persian cats.

Tamsulosin works faster, but both drugs have similar effects after 6 months.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Dermoscopy can help diagnose tuberous sclerosis by identifying unique skin patterns.

Emotional Freedom Techniques (EFT) treatment improved seed germination and growth, suggesting mood affects seed viability.

Daily subcutaneous testosterone effectively restores testosterone levels in men.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

The ethosomal formulation improved finasteride delivery through the skin.

Testosterone and finasteride improve muscle strength and size after spinal cord injury.

Overexpressing ATF3 in mice's epithelial cells may lead to oral cancer.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.